Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-001336
Filing Date
2019-01-03
Accepted
2019-01-03 18:40:54
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3712
  Complete submission text file 0001209191-19-001336.txt   5154
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2533 SOUTH COAST HIGHWAY 101 SUITE 210 CARDIFF-BY-THE-SEA CA 92007
Business Address
Simon Barry J. (Reporting) CIK: 0001647994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38327 | Film No.: 19507657